Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

The United States carries a staggering $36 trillion in national debt—a figure so astronomical it defies comprehension. While many point fingers at China as America's primary creditor, holding roughly $750 billion in U.S. bonds, the reality is far more complex. China itself is drowning in over $18 trillion of its own debt, creating an intricate web of global financial interdependence that challenges our understanding of who owes what to whom.

In recent years, retail investors have increasingly turned their attention to an unconventional source of trading inspiration: the stock market activities of U.S. Congress members. This strategy, while controversial, has gained traction as tools and platforms make congressional trading data more accessible than ever. But is following congressional stock picks a viable investment strategy? Let's dive deep into this intriguing approach.

Founded: 2020
Headquarters: Denver, Colorado
Market Cap: $1.2M (as of Q4 2024)
Share Price: $0.15
Regulatory Status: Research and development stage

Company Overview Founded: 2018 Headquarters: Knoxville, Tennessee Market Cap: $1.8M (as of Q4 2024) Share Price: $0.05 Regulatory Status: Operating ketamine clinics under existing medical regulations Company Link Revitalist Lifestyle and Wellness Ltd. Core Development Programs Primary Research Focus Clinical…

Founded: 2019
Headquarters: Toronto, Canada
Market Cap: $8.2M (as of Q4 2024)
Share Price: $0.12
Regulatory Status: Operating mental health clinics

The Psychedelic Renaissance: A New Frontier in Mental Health Treatment and Investment Opportunities

Bright Minds Biosciences (CSE: DRUG) - Psychedelic Medicine Company Analysis

Founded: 2019
Headquarters: Toronto, Canada
Market Cap: $18.5M (as of Q4 2024)
Share Price: $0.42
Regulatory Status: Operating clinics under existing healthcare regulations

Founded: 2018
Headquarters: Vancouver, Canada
Market Cap: $42.1M (as of Q4 2024)
Share Price: $0.16
Regulatory Status: Licensed by Health Canada for psychedelic research and therapy

Company Overview Founded: 2000 Headquarters: New York, NY and Petach Tikva, Israel Market Cap: $15.2M (as of Q4 2024) Share Price: $0.32 Regulatory Status: Phase 3 completed for NurOwn, FDA Advisory Committee review stage Company Link BrainStorm Cell Therapeutics Inc.…